BIOMEDICA Issued New Product: Soluble Semaphorin 4D ELISA
Update time：2018年05月24日
Biomedica is happy to announce the launch of a highly specific
soluble Semaphorin 4D ELISA
for the quantitative determination of human biologically active sSEMA4D in clinical samples
Highlights:
√GUARANTEED PERFORMANCE - rigorous validation and QCfor plasma samples in clinical trials
√ HIGHLY SPECIFIC - characterized antibodies and reagents
√ REPRODUCIBLE -specific analysis of soluble non-shed SEMA4D
√ RELIABLE - 7 human plasma based standards and 2 controls for biologically reliable data
√ LOW SAMPLE VOLUME - only 10 µl / well required
√ PROPRIETARY PRODUCT - in-house R&D and production
Areas of interest:
Osteology • Oncology • Immunology • Neurology
Semaphorin 4D is widely studied for its role in neural connectivity, vascularization, cell migration, the immune response, tumor progression, and bone remodeling.
